SLR Investment and Advanced Medical Isotope Compared in Head-to-Head Review

Analysts see more upside potential in SLR Investment stock compared to Advanced Medical Isotope.

Feb. 20, 2026 at 8:31pm

Got story updates? Submit your updates here. ›

Advanced Medical Isotope (OTCMKTS:RDGL) and SLR Investment (NASDAQ:SLRC) are both finance companies, but a review of the two companies' financials, risk profiles, analyst recommendations, and other factors shows SLR Investment is the stronger stock, according to analysts.

Why it matters

This comparison provides insight into the relative strengths and weaknesses of these two finance companies, which could be useful for investors looking to allocate capital in the sector.

The details

The analysis finds that SLR Investment has higher revenue and earnings than Advanced Medical Isotope. SLR Investment also has a stronger consensus rating from analysts and greater institutional ownership, both of which are positive indicators. Additionally, SLR Investment's stock is less volatile than the broader market, while Advanced Medical Isotope's stock is significantly more volatile.

  • The analysis was published on February 18, 2026.

The players

SLR Investment Corp.

A business development company that specializes in secured debt, subordinated debt, minority equity, and other investments in leveraged middle market companies across various sectors.

Advanced Medical Isotope (Vivos Inc.)

A radiation oncology medical device company that develops brachytherapy devices for the treatment of non-resectable tumors.

Got photos? Submit your photos here. ›

The takeaway

This analysis highlights SLR Investment's stronger financial performance, lower volatility, and more favorable analyst sentiment compared to Advanced Medical Isotope, suggesting SLR Investment may be the better investment option for those looking to allocate capital in the finance sector.